KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Cash & Current Investments (2016 - 2026)

Eli Lilly filings provide 18 years of Cash & Current Investments readings, the most recent being $5.3 billion for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 64.0% to $5.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $5.3 billion, a 64.0% increase, with the full-year FY2025 number at $7.3 billion, up 112.34% from a year prior.
  • Cash & Current Investments hit $5.3 billion in Q1 2026 for Eli Lilly, down from $7.3 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $9.9 billion in Q3 2025 to a low of $2.2 billion in Q4 2022.
  • Median Cash & Current Investments over the past 5 years was $3.2 billion (2025), compared with a mean of $3.8 billion.
  • Biggest five-year swings in Cash & Current Investments: crashed 43.41% in 2022 and later soared 181.76% in 2025.
  • Eli Lilly's Cash & Current Investments stood at $2.2 billion in 2022, then surged by 32.37% to $2.9 billion in 2023, then grew by 16.91% to $3.4 billion in 2024, then soared by 112.34% to $7.3 billion in 2025, then fell by 27.33% to $5.3 billion in 2026.
  • The last three reported values for Cash & Current Investments were $5.3 billion (Q1 2026), $7.3 billion (Q4 2025), and $9.9 billion (Q3 2025) per Business Quant data.